drugset / Trial / NCT01483586
Safety and Efficacy of Kanglaite Gelcaps in Prostate Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
This research is being done to evaluate the safety and efficacy of the investigational Kanglaite gelcap (KLTc) on PSA in men with prostate cancer when given for twelve months.
Timeline
- Start
- 2011-11
- Primary completion
- 2013-12
- Completion
- 2013-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Kanglaite | Traditional medicine (herbal / TCM) | 1.35 g | Oral |
| Subject | Kanglaite | Traditional medicine (herbal / TCM) | 2.7 g | Oral |